Can-Fite BioPharma Ltd.

CANF | AMEX

Price Alert Chart Builder DCF Calculator

$2.22

-$0.02 (-0.89%)

At close: Sep 21, 2026, 4:00 PM ET

$2.26

+$0.04 (+1.74%)

Pre-market: Sep 22, 2026, 6:16 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021	Q4 2020 Dec 30, 2020	Q3 2020 Sep 29, 2020	Q2 2020 Jun 29, 2020	Q1 2020 Mar 30, 2020
Net Income	-2.44M	-2.44M	-1.96M	-1.96M	-1.98M	-1.98M	-1.65M	-1.76M	-1.67M	-2.55M	-3.02M	-2.53M	-2.19M	-2.43M	-4.12M	-3.4M	-3.22M	-1.88M	-3.63M	-2.58M	-3.89M	-4.34M
Depreciation & Amortization	11.5K	11.5K	3K	3K	500	500	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	125.5K	125.5K	84.5K	84.5K	96.5K	96.5K	261K	-95K	95K	n/a	263K	-135K	135K	n/a	466K	-234K	234K	n/a	355K	-99K	99K	n/a
Other Working Capital	-278.5K	-278.5K	267.5K	267.5K	-322K	-322K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Non-Cash Items	203.5K	203.5K	-194K	-194K	185.5K	185.5K	1.39M	1.86M	1.58M	2.55M	2.76M	2.66M	2.06M	2.43M	3.65M	3.63M	2.99M	1.88M	3.28M	2.67M	3.79M	4.34M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-278.5K	-278.5K	267.5K	267.5K	-322K	-322K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Cash Flow	-2.38M	-2.38M	-1.8M	-1.8M	-2.02M	-2.02M	n/a	-95K	95K	n/a	263K	-135K	135K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Capital Expenditures	-500	-500	-500	-500	-2K	-2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	1.5M	1.5M	-1.5M	-1.5M	2.25M	2.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	1.5M	1.5M	-1.5M	-1.5M	2.25M	2.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.69M	1.69M	3.36M	3.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	1.69M	1.69M	3.36M	3.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Cash Flow	n/a	n/a	n/a	-4.72M	4.72M	n/a	n/a	-95K	95K	n/a	263K	-135K	135K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	-2.38M	-2.38M	-1.8M	-1.8M	-2.02M	-2.02M	n/a	-95K	95K	n/a	263K	-135K	135K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Adj. Free Cash Flow	-2.5M	-2.5M	-1.89M	-1.89M	-2.12M	-2.12M	-261K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-466K	234K	-234K	n/a	-355K	99K	-99K	n/a
Maintenance CapEx	-500	-500	n/a	-500	-2K	-2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	-500	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-2.38M	-2.38M	-1.8M	-1.8M	-2.02M	-2.02M	n/a	-95K	95K	n/a	263K	-135K	135K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a